|
|
| | | | | | Dear colleagues,
| | | | | | | | We are pleased to inform you that the abstract submission for the upcoming 13th International Symposium on Hodgkin Lymphoma (ISHL13) has been extended till 11:59 pm (CEST) on June 16th, 2024. | | | | | |
|
 |
| | | | | | Submit your abstract online | | | | | | | | Please submit your abstract at our submission page to actively shape the program of ISHL13 and share your work at the premier meeting for Hodgkin Lymphoma.
| | | | | | | | Notification of abstract acceptance will be sent to the presenting author by the beginning of August 2024.
| | | | | | | | All accepted abstracts will be published in a supplement of “HemaSphere”, the official journal of the European Hematology Association (EHA).
| | | | | | | | Awards will be granted to the best abstracts during the opening ceremony of the congress.
| | | | | | | | To ensure a quick and correct processing of your registration information, please use the online registration.
| | | | | |
|
| | | | | | ISHL13 will take place from October 26 to 28, 2024 in Cologne, Germany. Please visit our website for further information.
| | | | | |
|
| | All the best
| | | | | | | | Peter Borchmann, MD,
Symposium and GHSG Chairman | |
Sven Borchmann, MD/PhD,
Symposium Co-Chair | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
| | | | |
|
|
|
